Chester County News and Community Website
WILMINGTON, DE — Incyte Corp. (Nasdaq: INCY) is advancing two experimental cancer treatments into late-stage clinical development after early trials showed tumor responses in patients with pancreatic and colorectal cancers, …
Incyte Advances Pancreatic and Colorectal Cancer Drug Trials Read More
WASHINGTON, D.C. — The Food and Drug Administration approved Revolution Medicines Inc.’s Rasonque for certain adults with metastatic pancreatic adenocarcinoma after a clinical trial showed the drug nearly doubled median …
FDA Approves Rasonque as Pancreatic Cancer Treatment Read More WASHINGTON, D.C. — Federal regulators have cleared the way for certain pancreatic cancer patients to access an experimental drug earlier than usual, approving a rapid pathway that allows treatment outside …
FDA Fast-Tracks Access to Experimental Pancreatic Drug Read More
BERWYN, PA — Panavance Therapeutics Inc. has shared promising interim findings from its ongoing Phase 1 clinical trial investigating misetionamide (GP-2250), a novel second-line therapy for advanced pancreatic cancer. These …
Panavance Therapeutics Reports Promising Phase 1 Results for Pancreatic Cancer Therapy Read More
PLYMOUTH MEETING, PA — Research published in the April 2025 issue of JNCCN–Journal of the National Comprehensive Cancer Network has revealed stark disparities in the quality of care and outcomes …
Study Reveals Disparities in Care for Metastatic Pancreatic Cancer Patients Read More